369 related articles for article (PubMed ID: 10725985)
1. Effects on hemostasis after two-year use of low dose combined oral contraceptives with gestodene or levonorgestrel.
Prasad RN; Koh SC; Viegas OA; Ratnam SS
Clin Appl Thromb Hemost; 1999 Jan; 5(1):60-70. PubMed ID: 10725985
[TBL] [Abstract][Full Text] [Related]
2. The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives.
Norris LA; Bonnar J
Br J Obstet Gynaecol; 1996 Mar; 103(3):261-7. PubMed ID: 8630312
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 micrograms and 30 micrograms ethinylestradiol.
Winkler UH; Schindler AE; Endrikat J; Düsterberg B
Contraception; 1996 Feb; 53(2):75-84. PubMed ID: 8838483
[TBL] [Abstract][Full Text] [Related]
4. Effects on hemostatic variables of desogestrel- and gestodene-containing oral contraceptives in comparison with levonorgestrel-containing oral contraceptives: a review.
Winkler UH
Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 2):S51-61. PubMed ID: 9753311
[TBL] [Abstract][Full Text] [Related]
5. Studies on oral contraceptive-induced changes in blood coagulation and fibrinolysis and the estrogen effect on endothelial cells.
Quehenberger P; Kapiotis S; Pärtan C; Schneider B; Wenzel R; Gaiger A; Speiser W
Ann Hematol; 1993 Jul; 67(1):33-6. PubMed ID: 8392873
[TBL] [Abstract][Full Text] [Related]
6. The effect of levonorgestrel-releasing intrauterine system use on menstrual blood loss and the hemostatic, fibrinolytic/inhibitor systems in women with menorrhagia.
Koh SC; Singh K
J Thromb Haemost; 2007 Jan; 5(1):133-8. PubMed ID: 17010149
[TBL] [Abstract][Full Text] [Related]
7. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
[TBL] [Abstract][Full Text] [Related]
8. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
Notelovitz M; Kitchens CS; Khan FY
Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
[TBL] [Abstract][Full Text] [Related]
9. Double-blind, randomized, placebo controlled study on the effects of the monophasic oral contraceptive containing 30 micrograms ethinyl estradiol and 2.00 mg dienogest on the hemostatic system.
Spona J; Feichtinger W; Kindermann C; Schneider B; Mellinger U; Walter F; Moore C; Gräser T
Contraception; 1997 Aug; 56(2):67-75. PubMed ID: 9315414
[TBL] [Abstract][Full Text] [Related]
10. Hemostasis profile and lipid metabolism with long-interval use of a desogestrel-containing oral contraceptive.
Cachrimanidou AC; Hellberg D; Nilsson S; von Schoulz B; Crona N; Siegbahn A
Contraception; 1994 Aug; 50(2):153-65. PubMed ID: 7956214
[TBL] [Abstract][Full Text] [Related]
11. The effects of reformulated 2-rod Norplant implant on hemostasis after three years.
Viegas OA; Koh SC; Ratnam SS
Contraception; 1996 Oct; 54(4):219-28. PubMed ID: 8922875
[TBL] [Abstract][Full Text] [Related]
12. Effect of four oral contraceptives on hemostatic parameters.
Wiegratz I; Lee JH; Kutschera E; Winkler UH; Kuhl H
Contraception; 2004 Aug; 70(2):97-106. PubMed ID: 15288212
[TBL] [Abstract][Full Text] [Related]
13. Hemostatic effects of a novel estradiol-based oral contraceptive: an open-label, randomized, crossover study of estradiol valerate/dienogest versus ethinylestradiol/levonorgestrel.
Klipping C; Duijkers I; Parke S; Mellinger U; Serrani M; Junge W
Drugs R D; 2011; 11(2):159-70. PubMed ID: 21679006
[TBL] [Abstract][Full Text] [Related]
14. Maternal and cord blood hemostasis at delivery.
Schneider DM; von Tempelhoff GF; Herrle B; Heilmann L
J Perinat Med; 1997; 25(1):55-61. PubMed ID: 9085204
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled double-blind study of the effects on hemostasis of two progestogen-only pills containing 75 microgram desogestrel or 30 microgram levonorgestrel.
Winkler UH; Howie H; Bühler K; Korver T; Geurts TB; Coelingh Bennink HJ
Contraception; 1998 Jun; 57(6):385-92. PubMed ID: 9693398
[TBL] [Abstract][Full Text] [Related]
16. Effects of two combined monophasic and triphasic ethinylestradiol/gestodene oral contraceptives on natural inhibitors and other hemostatic variables.
Creatsas G; Kontopoulou-Griva I; Deligeoroglou E; Digenopoulou L; Tsangaris A; Kallipolitis G; Milingos S; Michalas S
Eur J Contracept Reprod Health Care; 1997 Mar; 2(1):31-8. PubMed ID: 9678107
[TBL] [Abstract][Full Text] [Related]
17. Effect of two low-dose gestodene containing monophasic oral contraceptives on hemostasis in Bulgarian women.
Uchikova E; Pehlivanov B
Expert Opin Pharmacother; 2008 Aug; 9(11):1839-44. PubMed ID: 18627323
[TBL] [Abstract][Full Text] [Related]
18. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
[TBL] [Abstract][Full Text] [Related]
19. Haemostatic changes and the oral contraceptive pill.
Norris LA; Bonnar J
Baillieres Clin Obstet Gynaecol; 1997 Sep; 11(3):545-64. PubMed ID: 9488791
[TBL] [Abstract][Full Text] [Related]
20. Effect of levonorgestrel contraceptive implants, Norplant, on blood coagulation.
Shaaban MM; Elwan SI; el-Kabsh MY; Farghaly SA; Thabet N
Contraception; 1984 Nov; 30(5):421-30. PubMed ID: 6440738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]